John W. Martens
3Patents
2h-index
25Co-inventors
37Inventor score
Filing activity: Oct 1, 2003 → Sep 21, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8101359B2 | Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy | Chemistry; Metallurgy | 3 | Expired |
| US9017944B2 | Methods for the prognosis of breast cancer | Chemistry; Metallurgy | 2 | Active |
| US10053735B2 | Markers for the prediction of outcome of anthracycline treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.